Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis BInfluenza and Pneumococcal vaccination

  • Innate immunity and diabetes vaccines
  • Central nervous system-targeted & Tissue-specific autoimmunity
  • Vaccines for immunodeficiency diseases
  • Vaccines for autoimmune skin disorders & neuropathies
  • Vaccination strategy in patients with IMID
  • Vaccine safety: impact on disease activity in IMID patients
  • Vaccinations in patients with immune-mediated inflammatory diseases

Related Conference of Vaccines for Immune Mediated Diseases

July 27-28, 2018

31st Annual Congress on Vaccines, Clinical Trials & B2B

Vancouver, Canada
September 19-20, 2018

International Congress on Vaccines & Immunology

Amsterdam, Netherlands
October 22-23, 2018

30th World Congress on Vaccines and Immunization

Osaka, Japan
March 18-19, 2019

33rdAnnual Vaccines & Vaccination Congress

New York, USA

Vaccines for Immune Mediated Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in